Dear Healthcare Provider Letter - How is Dear Healthcare Provider Letter abbreviated?
DHCP (redirected from Dear Healthcare Provider Letter)
|DHCP||Dynamic Host Configuration Protocol (protocol for automating the configuration of computers that use TCP/IP)|
|DHCP||Dynamic Host Configuration Protocol|
|DHCP||Decentralized Hospital Computer Program|
|DHCP||Delaware Healthy Children Program (insurance)|
|DHCP||Dual Hydrogen Control Panel (Environment One)|
|DHCP||Double Hexagonal Close-Packed (crystals)|
|DHCP||Dear Healthcare Provider Letter (healthcare industry)|
|DHCP||Dental Healthcare Personnel|
|DHCP||Draco Holding Company (stock symbol)|
|DHCP||Defense Health Care Program (US DoD)|
References in periodicals archive
The company plans to issue a Dear Healthcare Provider letter
to potential prescribers and pharmacists to make them aware of the Triad product recall and the need to discontinue use of the alcohol prep pads packaged with Boniva Injection, Fuzeon, Nutropin A.
NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva([R]) (efalizumab) for approximately four years for treatment of chronic plaque psoriasis.
A Dear Healthcare Provider letter was issued in early October to inform healthcare providers of the first reported case of PML.
NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had received Raptiva([R]) (efalizumab) for more than four years for treatment of chronic plaque psoriasis.
Information about this other case is also included in the Dear Healthcare Provider letter issued today.
A Dear Healthcare Provider letter
has been sent to physicians to enhance their understanding of adverse events that may be associated with Rituxan use.
Dear Healthcare Provider letters
were issued to inform prescribers about the risk of PML with Raptiva as these cases were identified.